GB201502840D0 - Cancer prognostic - Google Patents

Cancer prognostic

Info

Publication number
GB201502840D0
GB201502840D0 GB201502840A GB201502840A GB201502840D0 GB 201502840 D0 GB201502840 D0 GB 201502840D0 GB 201502840 A GB201502840 A GB 201502840A GB 201502840 A GB201502840 A GB 201502840A GB 201502840 D0 GB201502840 D0 GB 201502840D0
Authority
GB
United Kingdom
Prior art keywords
cancer prognostic
prognostic
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201502840A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Cardiff Consultants Ltd
Cardiff University
Original Assignee
University College Cardiff Consultants Ltd
Cardiff University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College Cardiff Consultants Ltd, Cardiff University filed Critical University College Cardiff Consultants Ltd
Priority to GB201502840A priority Critical patent/GB201502840D0/en
Publication of GB201502840D0 publication Critical patent/GB201502840D0/en
Priority to PCT/GB2016/050357 priority patent/WO2016132103A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB201502840A 2015-02-20 2015-02-20 Cancer prognostic Ceased GB201502840D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201502840A GB201502840D0 (en) 2015-02-20 2015-02-20 Cancer prognostic
PCT/GB2016/050357 WO2016132103A1 (en) 2015-02-20 2016-02-15 Cancer prognostic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201502840A GB201502840D0 (en) 2015-02-20 2015-02-20 Cancer prognostic

Publications (1)

Publication Number Publication Date
GB201502840D0 true GB201502840D0 (en) 2015-04-08

Family

ID=52821908

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201502840A Ceased GB201502840D0 (en) 2015-02-20 2015-02-20 Cancer prognostic

Country Status (2)

Country Link
GB (1) GB201502840D0 (en)
WO (1) WO2016132103A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients

Also Published As

Publication number Publication date
WO2016132103A1 (en) 2016-08-25

Similar Documents

Publication Publication Date Title
IL255217A0 (en) Cancer neoepitopes
GB201420908D0 (en) Biomarkers
GB201401603D0 (en) Biomarkers
SG10202007262PA (en) Copanlisib biomarkers
GB201500584D0 (en) Cancer biomarkers
SG10202007322PA (en) Copanlisib biomarkers
DK3292140T3 (en) Immunterapeutikum mod cancer
TWI563730B (en) Complex antenna
GB201614455D0 (en) Biomarkers
HK1245120A1 (en) Novel therapies for cancer
PT3198034T (en) Biomarkers for cervical cancer.
GB201508934D0 (en) Antenna
GB201515664D0 (en) Antenna
ZA201804206B (en) Amylose-lipid complexes
GB201513692D0 (en) Antenna
GB201500729D0 (en) Novel Biomarkers
HK1249134A1 (en) Biomarkers for colorectal cancer related diseases
GB201508480D0 (en) Cancer
GB201512133D0 (en) Biomarkers
GB2546773B (en) Cancer
GB201521481D0 (en) Prognostic system
GB201517585D0 (en) Secure slide
GB201502840D0 (en) Cancer prognostic
GB201703641D0 (en) Cancer biomarkers
GB201519704D0 (en) Biomarkers

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)